Investigative Ophthalmology & Visual Science, Vol 36, 1201-1214, Copyright © 1995 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis

T Chan-Ling, B Gock and J Stone
Department of Anatomy and Histology, University of Sydney, New South Wales, Australia.

PURPOSE. To assess the role of oxygen in normal retinal vasculogenesis. METHODS. A new preparation for studying cytogenesis in retinal wholemounts was developed. Nuclei of dividing cells were labeled with a monoclonal antibody to bromodeoxyuridine (BrdU), and vascular cells were covisualized with Griffonia simplicifolia lectin. The topography and time course of vasculogenic cell division and vessel formation were determined in the kitten retina during normal development and under experimental hyperoxia and hypoxia. RESULTS. During normal development, vasculogenic cell division was maximal at the leading edge of the forming vessels. Normal vessel formation was initially proliferative, and cell division was high. However, after vessel formation occurred, which presumably relieved tissue hypoxia, the mitogenic process was markedly reduced, and many excess capillary segments underwent retraction. The rate of vasculogenic cell division and vessel formation increased when the inner layers of the retina were made avascular after exposure to hyperoxia, and it decreased when there was an increase in inspired oxygen. CONCLUSIONS. The authors have shown that between 17% and 45% oxygen, the extent of vasculogenic cell division is inversely proportional to the level of oxygen in the inspired gas mixture. They have further shown that dividing vascular cells have a peak density in a region proximal to the edge of the forming vasculature. The density is maximal between P7 and P8, a time when formation of photoreceptor outer segment begins, only a few days before the onset of retinal function. These results led the authors to conclude that the stimulus for normal vasculogenesis is a transient but physiological level of hypoxia induced by the increasing activity of retinal neurons.

This article has been cited by other articles:

				C. Clapp, S. Thebault, E. Arnold, C. Garcia, J. C. Rivera, and G. M. de la Escalera Vasoinhibins: novel inhibitors of ocular angiogenesis Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E772 - E778. [Abstract] [Full Text] [PDF]

				M. E. Hartnett, D. Martiniuk, G. Byfield, P. Geisen, G. Zeng, and V. L. Bautch Neutralizing VEGF Decreases Tortuosity and Alters Endothelial Cell Division Orientation in Arterioles and Veins in a Rat Model of ROP: Relevance to Plus Disease Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3107 - 3114. [Abstract] [Full Text] [PDF]

				T. Hasegawa, D. S. McLeod, T. Prow, C. Merges, R. Grebe, and G. A. Lutty Vascular Precursors in Developing Human Retina Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2178 - 2192. [Abstract] [Full Text] [PDF]

				D A Todd, A Wright, J Smith, and the NICUS Group Severe retinopathy of prematurity in infants <30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002 Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F251 - F254. [Abstract] [Full Text] [PDF]

				S. Hughes, T. Gardiner, L. Baxter, and T. Chan-Ling Changes in Pericytes and Smooth Muscle Cells in the Kitten Model of Retinopathy of Prematurity: Implications for Plus Disease Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1368 - 1379. [Abstract] [Full Text] [PDF]

				T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. M. Curtis, T. A. Gardiner, and A. W. Stitt Rod Photoreceptor Loss in Rho-/- Mice Reduces Retinal Hypoxia and Hypoxia-Regulated Gene Expression Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5553 - 5560. [Abstract] [Full Text] [PDF]

				D. Checchin, F. Sennlaub, E. Levavasseur, M. Leduc, and S. Chemtob Potential role of microglia in retinal blood vessel formation. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3595 - 3602. [Abstract] [Full Text] [PDF]

				A. V. Ljubimov, S. Caballero, A. M. Aoki, L. A. Pinna, M. B. Grant, and R. Castellon Involvement of Protein Kinase CK2 in Angiogenesis and Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4583 - 4591. [Abstract] [Full Text] [PDF]

				T. Chan-Ling, M. P. Page, T. Gardiner, L. Baxter, E. Rosinova, and S. Hughes Desmin Ensheathment Ratio as an Indicator of Vessel Stability: Evidence in Normal Development and in Retinopathy of Prematurity Am. J. Pathol., October 1, 2004; 165(4): 1301 - 1313. [Abstract] [Full Text] [PDF]

				T. Chan-Ling, D. S. McLeod, S. Hughes, L. Baxter, Y. Chu, T. Hasegawa, and G. A. Lutty Astrocyte-Endothelial Cell Relationships during Human Retinal Vascular Development Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 2020 - 2032. [Abstract] [Full Text] [PDF]

				A. Madan Angiogenesis and Antiangiogenesis in the Neonate: Relevance to Retinopathy of Prematurity NeoReviews, December 1, 2003; 4(12): e356 - 363. [Full Text] [PDF]

				W. Zhang, Y. Ito, E. Berlin, R. Roberts, and B. A. Berkowitz Role of Hypoxia during Normal Retinal Vessel Development and in Experimental Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3119 - 3123. [Abstract] [Full Text] [PDF]

				J. L. Wilkinson-Berka, N. S. Alousis, D. J. Kelly, and R. E. Gilbert COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 974 - 979. [Abstract] [Full Text] [PDF]

				S. A. Feeney, D. A. C. Simpson, T. A. Gardiner, C. Boyle, P. Jamison, and A. W. Stitt Role of Vascular Endothelial Growth Factor and Placental Growth Factors During Retinal Vascular Development and Hyaloid Regression Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 839 - 847. [Abstract] [Full Text] [PDF]

				C M Wheatley, J L Dickinson, D A Mackey, J E Craig, and M M Sale Retinopathy of prematurity: recent advances in our understanding Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2002; 87(2): F78 - 82. [Abstract] [Full Text] [PDF]

				C M Wheatley, J L Dickinson, D A Mackey, J E Craig, and M M Sale Retinopathy of prematurity: recent advances in our understanding Br. J. Ophthalmol., June 1, 2002; 86(6): 696 - 700. [Abstract] [Full Text] [PDF]

				J. S. Penn, V. S. Rajaratnam, R. J. Collier, and A. F. Clark The Effect of an Angiostatic Steroid on Neovascularization in a Rat Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 283 - 290. [Abstract] [Full Text]

				Y. Hasebe, L. R. Thomson, and C. K. Dorey Pentoxifylline Inhibition of Vasculogenesis in the Neonatal Rat Retina Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2774 - 2778. [Abstract] [Full Text]

				S. Hughes, H. Yang, and T. Chan-Ling Vascularization of the Human Fetal Retina: Roles of Vasculogenesis and Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1217 - 1228. [Abstract] [Full Text]

				The STOP-ROP Multicenter Study Group Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes Pediatrics, February 1, 2000; 105(2): 295 - 310. [Abstract] [Full Text]

				G. A. Lutty, C. Merges, and D. S. McLeod 5' Nucleotidase and Adenosine during Retinal Vasculogenesis and Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 218 - 229. [Abstract] [Full Text]

				M. Taomoto, D. S. McLeod, C. Merges, and G. A. Lutty Localization of Adenosine A2a Receptor in Retinal Development and Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 230 - 243. [Abstract] [Full Text]

				A. Hellstrom, L.-M. Wiklund, E. Svensson, K. Albertsson-Wikland, and K. Stromland Optic Nerve Hypoplasia With Isolated Tortuosity of the Retinal Veins: A Marker of Endocrinopathy Arch Ophthalmol, July 1, 1999; 117(7): 880 - 884. [Abstract] [Full Text] [PDF]